Company Profile
SOL S.p.A. produces and distributes technical and medical gases for industry and healthcare facilities in Italy and internationally. The company supplies technical gases, equipment, systems, and services for the industrial sectors; and produces and distributes gases, such as oxygen, nitrogen, argon, hydrogen, carbon dioxide, sulphur dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, gaseous helium, liquid helium, gases for electronics, ammonia, combustible gases for industrial use, and liquefied natural gas. It also provides medical gases with AIC and medical devices, training services, electromedical equipment services, hospital hygiene and environmental monitoring, ambulance management, design and development of biobanks, and InfoHealth solutions; and respiratory and infusion therapies, healthcare and social care services, telemedicine and digital services, and healthcare aids. In addition, the company offers CRYOLAB for transfer, storage and handling services of biological samples; DIATHEVA, which focuses on research, development, production, and marketing products, including monoclonal antibodies, recombinant proteins, and molecular kits for hospital research, diagnosis and clinical application, environmental, veterinary, and food; and PERSONAL GENOMICS for preventive and precision medicine. SOL S.p.A. was founded in 1927 and is headquartered in Monza, Italy. SOL S.p.A. operates as a subsidiary of Gas And Technologies World B.V.
Latest News
Goldman Sachs leads oil and gas M&A advisory by value in H1 2026
Philippines' Marcos says 'perhaps time to revisit nuclear energy'
Camden National Bank Earnings: What To Look For From CAC
Black Book Expands Vendor-Agnostic Healthcare Supply Chain Technology Benchmark to 36 Categories for AHRMM26
Target Hospitality Announces New $660 Million Credit Facility, Significantly Expanding Liquidity and Lowering Cost of Capital to Support Strategic Growth
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Website | https://www.solgroup.com |
| Audit Risk | 5 |
| Board Risk | 10 |
| Overall Risk | 10 |
| Market Cap | 5.67B |
| Trailing P/E | 33.99 |
| Forward P/E | 28.22 |
| Dividend Rate | 0.45 |
| Dividend Yield | 0.72% |
| Trailing Annual Div. Rate | 0.45 |
| Trailing Annual Div. Yield | 0.72% |
| Trailing EPS | 1.84 |
| Forward EPS | 2.22 |
| Book Value | 12.54 |
| Price-to-Book | 4.99 |
| Enterprise-to-Revenue | 3.45 |
| Enterprise-to-EBITDA | 15.17 |
| Ex-Dividend Date | 05/18/2026 |
| Earnings Date | |
| Earnings Call Date | |
| Revenue Average | 468.00M |
| Revenue Low | 468.00M |
| Revenue High | 468.00M |